Design of Cyclopentaisoxazoline Amino Acids as Conformationally Constrained Agonists at Glutamate Receptors
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Design of Cyclopentaisoxazoline Amino Acids as Conformationally Constrained Agonists at Glutamate Receptors. / Conti, Paola; De Amici, Marco; Grazioso, Giovanni; Roda, Gabriella; Stensbøl, Tine B.; Bräuner-Osborne, Hans; Madsen, Ulf; Toma, Lucio; De Micheli, Carlo.
In: European Journal of Organic Chemistry, No. 22, 14.11.2003, p. 4455-4461.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Design of Cyclopentaisoxazoline Amino Acids as Conformationally Constrained Agonists at Glutamate Receptors
AU - Conti, Paola
AU - De Amici, Marco
AU - Grazioso, Giovanni
AU - Roda, Gabriella
AU - Stensbøl, Tine B.
AU - Bräuner-Osborne, Hans
AU - Madsen, Ulf
AU - Toma, Lucio
AU - De Micheli, Carlo
PY - 2003/11/14
Y1 - 2003/11/14
N2 - We have prepared four isomeric 3-hydroxycyclopentaisoxazohne amino acids 12-15, which represent analogues of glutamic acid having restricted conformations, through a strategy based on the 1,3-dipolar cycloaddition of bromonitrile oxide to a suitably protected 1-aminocyclopent-2-enecarboxylic acid. These target compounds proved to be inactive when assayed at ionotropic and metabotropic glutamate receptors, except for 12 which is an agonist primarily at mGluR5 (EC50 = 79 μM), but is less active at mGluR2 and only marginally active at mGluR1. The biological data are accounted for through comparison of the conformational profiles of the test compounds with that of reference agonists, i.e., N-methyl-D-aspartate (NMDA, 2), and 1-aminocyclopentane-1,3-dicarboxylic acids [trans-ACPD, 10; cis-ACPD, 11].
AB - We have prepared four isomeric 3-hydroxycyclopentaisoxazohne amino acids 12-15, which represent analogues of glutamic acid having restricted conformations, through a strategy based on the 1,3-dipolar cycloaddition of bromonitrile oxide to a suitably protected 1-aminocyclopent-2-enecarboxylic acid. These target compounds proved to be inactive when assayed at ionotropic and metabotropic glutamate receptors, except for 12 which is an agonist primarily at mGluR5 (EC50 = 79 μM), but is less active at mGluR2 and only marginally active at mGluR1. The biological data are accounted for through comparison of the conformational profiles of the test compounds with that of reference agonists, i.e., N-methyl-D-aspartate (NMDA, 2), and 1-aminocyclopentane-1,3-dicarboxylic acids [trans-ACPD, 10; cis-ACPD, 11].
KW - Amino acids
KW - Glutamate analogues
KW - Heterocycles
KW - Receptors
UR - http://www.scopus.com/inward/record.url?scp=0344442695&partnerID=8YFLogxK
U2 - 10.1002/ejoc.200300424
DO - 10.1002/ejoc.200300424
M3 - Journal article
AN - SCOPUS:0344442695
SP - 4455
EP - 4461
JO - European Journal of Organic Chemistry
JF - European Journal of Organic Chemistry
SN - 1434-193X
IS - 22
ER -
ID: 379295810